The Patent Finder

Shire Laboratories, Inc.

Also on record
Records under this name other than patents Shire Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Shire Laboratories, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,749,532Once Daily Formulations of Tetracyclines
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,611,728Osmotic Delivery of Therapeutic Compounds by Solubility Enhancement
Formerly held
Term ended
Term ended Sep 14, 2025 · High confidence
Term endedTerm ended Sep 14, 2025High confidence
US 8,193,211Controlled Release Compositions of Gamma-Hydroxybutyrate
Formerly held
Lapsed on the fee record
Ended Jun 5, 2024 · High confidence
Lapsed on the fee recordEnded Jun 5, 2024High confidence
US 9,308,176Less Abusable Pharmaceutical Preparations
Formerly held
Lapsed on the fee record
Ended Apr 12, 2024 · High confidence
Lapsed on the fee recordEnded Apr 12, 2024High confidence
US 6,913,768Sustained Release Delivery of Amphetamine Salts
Formerly held
Term ended
Term ended May 24, 2023 · High confidence
Term endedTerm ended May 24, 2023High confidence
US 7,910,128Use of a Mixture of Two or More Enteric Materials to Regulate Drug Release via Membrane or Matrix for Systemic Therapeutics
Formerly held
Lapsed on the fee record
Ended Mar 22, 2023 · High confidence
Lapsed on the fee recordEnded Mar 22, 2023High confidence
US 8,906,413Drug formulations having reduced abuse potential
Formerly held
Lapsed on the fee record
Ended Dec 9, 2022 · High confidence
Lapsed on the fee recordEnded Dec 9, 2022High confidence
US 6,811,794Sustained Release Pharmaceutical Dosage Forms with Minimized PH Dependent Dissolution Profiles
Formerly held
Term ended
Term ended Jul 4, 2022 · High confidence
Term endedTerm ended Jul 4, 2022High confidence
US 6,838,093System for Osmotic Delivery of Pharmaceutically Active Agents
Formerly held
Term ended
Term ended Jun 1, 2021 · High confidence
Term endedTerm ended Jun 1, 2021High confidence
US 6,287,599Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
Formerly held
Term ended
Term ended Dec 20, 2020 · USPTO record
Term endedTerm ended Dec 20, 2020USPTO record
10 of 41 patents shown.
Pro members see all 41.
Pro members: see all 41 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited